MedPath

The Effects of Omega-3 plus Vitamin E on Metabolic Syndrome Indicators And insulin resistance in Overweight Women with Polycystic Ovary Syndrome

Phase 3
Conditions
Polycystic ovary syndrome.
Registration Number
IRCT20200812048379N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
64
Inclusion Criteria

oligo-ovulation or anovulation
the manifestation of hyper-androgenemia or symptom of hyperandrogenism
the viewing of polycystic ovaries in ultrasound

Exclusion Criteria

cardiovascullar deases
kidney diseases
diabetes
Cushing's syndrome were
hepatitis
non-alcoholic fatty liver
thyroid disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath